N-of-One - Ownership and Business Overview

Life ScienceCompany

N-of-One Ownership

Who owns N-of-One?

N-of-One is owned by Qiagen N.V. It was acquired on January 7, 2019.

N-of-One Business Overview

Where is N-of-One headquartered?

N-of-One is headquartered in Concord, Massachusetts.

How many employees does N-of-One have?

N-of-One has 41 employees.

What sector is N-of-One in?

N-of-One is a life science company.

When was N-of-One founded?

N-of-One was founded in 2008.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Subscribe to Mergr to view all 252 acquisitions of life science companies in 2019, including 45 acquisitions by private equity firms, and 207 by strategics.

N-of-One, Inc.

561 Virginia Road, Suite 300,
Concord, Massachusetts 01742
United States,
(617) 202-9808
www.n-of-one.com

N-of-One, Inc. is a provider in clinical interpretation of molecular tests in oncology. N-of-One solutions can standardize and accelerate genomic clinical interpretation and molecular decision support while saving time and money. N-of-One, Inc. was founded in 2008 and is based in Concord, Massachusetts.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for N-of-One

Life Science Companies